People: Bio-Techne Corp (TECH.OQ)
15 Nov 2019
Mr. David Eansor is a Senior Vice President - Biotechnology of the Company. Prior to that, Mr. Eansor was Senior Vice President, Novus Biologicals, since the Company completed its acquisition of Novus on July 2, 2014. From January 2013 until the date of the acquisition, Mr. Eansor was the Senior Vice President of Corporate Development of Novus Biologicals. Prior to joining Novus, Mr. Eansor was the President of the Bioscience Division of Thermo Fisher Scientific. Mr. Eansor was promoted to Division President in early 2010 after 5 years as President of Thermo Fisher’s Life Science Research business.
|Total Annual Compensation, USD||686,210|
|Restricted Stock Award, USD||162,522|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||498,473|
|Fiscal Year Total, USD||1,347,200|